James R. Langabeer II is an American decision scientist, academic, and entrepreneur known for his theories on strategy and decision-making.
[1] Langabeer is most known for his research on integrated theories of decision-making, collaboration, management strategy, and financial intelligence, especially in medicine and healthcare.
[17] While focusing his research on telehealth-enabled emergency medical services program, he found out the efficacy of mobile technology-driven delivery models in terms of reducing unnecessary ED ambulance transports and increasing EMS unit productivity.
He has investigated how non-profit organizations create decisions and strategically respond to financial distress when faced with potential for bankruptcy or closure.
[19] In 2021, he co-authored insights regarding cardiovascular health (CVH) trajectories in time-series electronic health records with artificial intelligence models, after having an analysis of the predictions of 5 CVH submetrics, including smoking status (SMK), body mass index (BMI), blood pressure (BP), hemoglobin A1c (A1C), and low-density lipoprotein (LDL).
"[21] In 2012, he explored how dispositional optimism affects the relationship that exists between rational decision-making processes and organizational performance.